Fifth Lane Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,917
Closed -$384K 50
2024
Q3
$384K Buy
+6,917
New +$384K 0.97% 15